(S)-2-(4-Hydroxybutan-2-yl)isoindoline-1,3-dione

Catalog No.: 
ACTEAT872
CAS No.: 
545376-10-1
Molecular Formula: 
C12H13NO3
Molecular Weight: 
219.24
(S)-2-(4-Hydroxybutan-2-yl)isoindoline-1,3-dione structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$207.00InquiryInquiry
250mg95%$377.00InquiryInquiry
1g95%$1478.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(S)-2-(4-Hydroxybutan-2-yl)isoindoline-1,3-dione
IUPAC Name(S)-2-(4-hydroxybutan-2-yl)isoindoline-1,3-dione
MDL No.MFCD09038002
Molecular FormulaC12H13NO3
Molecular Weight219.24
SMILESO=C1N([C@@H](C)CCO)C(C2=C1C=CC=C2)=O
InChI KeyRJAMSKDRWYAMGF-QMMMGPOBSA-N
Synonym(R)-2-(4-hydroxybutan-2-yl)isoindoline-1,3-dione;2-((S)-4-HYDROXYBUTAN-2-YL)ISOINDOLINE-1,3-DIONE;2-[(1S)-3-HYDROXY-1-METHYLPROPYL]-1H-ISOINDOLE-1,3(2H)-DIONE;2-[(2S)-4-hydroxybutan-2-yl]isoindole-1,3-dione;1H-Isoindole-1,3(2H)-dione, 2-[(1S)-3-hydroxy-1-methylpropyl]-;PO-2008050303-P-309
CAS No.545376-10-1

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACTEAT872 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACTEAT872 route product structure diagram
    ACTEAT872545376-10-1
Inquiry

2. ACTEAT872 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACTEAT872 route product structure diagram
    ACTEAT872545376-10-1
Inquiry

3. ACTEAT872 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACTEAT872 route product structure diagram
    ACTEAT872545376-10-1
Inquiry

Comments (0)